# UniQure

- Headquarters: Netherlands


## Customers, suppliers and deals

- [CSL Behring](https://endata.com/companies/28726.md): customer, 2×, latest 2020-06-25

## Announcements (2)

- 2020-06-25: [CSL Behring acquires global commercialization rights to uniQure's hemophilia B gene therapy AMT-061](https://endata.com/announcements/49558-csl-behring-acquires-global-commercialization-rights-to-uniqure-s-hemophilia-b) (Contract · $450.0M)
- 2020-06-25: [UniQure grants CSL Behring global rights to hemophilia B gene therapy](https://endata.com/announcements/49554-uniqure-grants-csl-behring-global-rights-to-hemophilia-b-gene-therapy) (Contract · $2.00B)

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.